Subscribe To

Price Alert Latest News Economic Calendar News

SYF / Synchrony Financial (SYF) CEO Brian Doubles on Q2 2022 Results - Earnings Call Transcript

Synchrony Financial (NYSE:SYF ) Q2 2022 Results Conference Call July 18, 2022 8:00 AM ET Company Participants Kathryn Miller - Senior Vice President, Investor Relations Brian Doubles - President and Chief Executive Officer Brian Wenzel - Executive Vice President and Chief Financial Officer Conference Call Participants Ryan Nash - Goldman Sachs Moshe Orenbuch - Credit Suisse Betsy Graseck - Morgan Stanley John Pancari - Evercore ISI Sanjay Sakhrani - KBW Mihir Bhatia - Bank of America Brian Foran - Autonomous Research Kevin Barker - Piper Sandler Mark DeVries - Barclays Operator Welcome to the Synchrony Financial Second Quarter 2022 Earnings Conference Call. My name is Vanessa, and I will be your operator for today's call. Read More

Demo Live Account See Partner Details

Content Topics

Synchrony

Financial

SYF

Brian

Doubles

2022

Results

Earnings

Transcript

Stock

Posted: Jul 18 2022, 12:55

Author Name: Seeking Alpha

SYF News

By Zacks Investment Research
October 24, 2023

Synchrony (SYF) Q3 Earnings Beat on Growing Purchase Volume

Synchrony (SYF) expects loan receivables to grow 11% for 2023, up from the previous guidance of 8-10%.

By Zacks Investment Research
October 24, 2023

Synchrony (SYF) Beats Q3 Earnings and Revenue Estimates

Synchrony (SYF) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earning

By Zacks Investment Research
October 19, 2023

Will Rising Expenses Affect Synchrony's (SYF) Q3 Earnings?

Synchrony's (SYF) third-quarter results are likely to reflect lower net interest margins and higher total average active accounts.

By Zacks Investment Research
October 13, 2023

Should Value Investors Buy Synchrony Financial (SYF) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe

By Zacks Investment Research
October 11, 2023

Synchrony (SYF) & Veterinary Growth to Offer Pet Care Financing

Synchrony (SYF) collaborates with Veterinary Growth to provide pet care financing solutions to its members.

By Seeking Alpha
October 6, 2023

Synchrony: A Buy As Credit Deterioration Slows

Shares of Synchrony Financial have been falling due to concerns about rising credit card delinquencies. Despite underperforming expectations, SYF stoc

By Zacks Investment Research
September 18, 2023

Here's Why Investors Are Retaining Synchrony (SYF) Stock Now

Synchrony's (SYF) Health & Wellness platform is expected to continue its growth track, thanks to a solid CareCredit brand.

By Zacks Investment Research
August 30, 2023

Synchrony (SYF) Offers Financing Options in Dental Care

Synchrony Financial (SYF) ties up with Specialty1 Partners to extend financing alternatives to customers opting for dental care, as well as shield the

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.